IT201600122310A1 - Composizione per uso nella terapia di alterazioni dell'intestino - Google Patents
Composizione per uso nella terapia di alterazioni dell'intestinoInfo
- Publication number
- IT201600122310A1 IT201600122310A1 IT102016000122310A IT201600122310A IT201600122310A1 IT 201600122310 A1 IT201600122310 A1 IT 201600122310A1 IT 102016000122310 A IT102016000122310 A IT 102016000122310A IT 201600122310 A IT201600122310 A IT 201600122310A IT 201600122310 A1 IT201600122310 A1 IT 201600122310A1
- Authority
- IT
- Italy
- Prior art keywords
- treatment
- composition
- bowel disorders
- bowel
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (22)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102016000122310A IT201600122310A1 (it) | 2016-12-01 | 2016-12-01 | Composizione per uso nella terapia di alterazioni dell'intestino |
| PL17822783.1T PL3548006T3 (pl) | 2016-12-01 | 2017-12-01 | Kompozycja do stosowania w leczeniu zmian jelitowych |
| AU2017368931A AU2017368931B2 (en) | 2016-12-01 | 2017-12-01 | Composition for use in the treatment of intestinal alterations |
| DK17822783.1T DK3548006T3 (da) | 2016-12-01 | 2017-12-01 | Sammensætning til behandling af tarmforandringer |
| LTEPPCT/IB2017/057580T LT3548006T (lt) | 2016-12-01 | 2017-12-01 | Kompozicija, skirta žarnyno pakitimams gydyti |
| KR1020197018872A KR102508323B1 (ko) | 2016-12-01 | 2017-12-01 | 장 변이를 치료하는데 사용하기 위한 조성물 |
| US16/465,511 US10881703B2 (en) | 2016-12-01 | 2017-12-01 | Composition for use in the treatment of intestinal alterations |
| BR112019011007A BR112019011007A2 (pt) | 2016-12-01 | 2017-12-01 | composição para uso no tratamento de alterações intestinais |
| CN201780074055.9A CN110430870B (zh) | 2016-12-01 | 2017-12-01 | 用于治疗肠改变的组合物 |
| RS20231235A RS65009B1 (sr) | 2016-12-01 | 2017-12-01 | Sastav za upotrebu u lečenju crevnih promena |
| HUE17822783A HUE065202T2 (hu) | 2016-12-01 | 2017-12-01 | Készítmény bélelváltozások kezelésében való felhasználásra |
| PCT/IB2017/057580 WO2018100551A1 (en) | 2016-12-01 | 2017-12-01 | Composition for use in the treatment of intestinal alterations |
| RU2019120187A RU2772870C2 (ru) | 2016-12-01 | 2017-12-01 | Композиция для применения при лечении кишечных повреждений |
| JP2019549668A JP7321935B2 (ja) | 2016-12-01 | 2017-12-01 | 腸管変化の処置において使用する組成物 |
| SI201731468T SI3548006T1 (sl) | 2016-12-01 | 2017-12-01 | Sestava za uporabo pri zdravljenju črevesnih sprememb |
| CA3045267A CA3045267A1 (en) | 2016-12-01 | 2017-12-01 | Composition for use in the treatment of intestinal alterations |
| HRP20231691TT HRP20231691T1 (hr) | 2016-12-01 | 2017-12-01 | Pripravak za upotrebu u liječenju promjena u crijevima |
| FIEP17822783.1T FI3548006T3 (fi) | 2016-12-01 | 2017-12-01 | Koostumus käytettäväksi suoliston muutosten hoidossa |
| EP17822783.1A EP3548006B1 (en) | 2016-12-01 | 2017-12-01 | Composition for use in the treatment of intestinal alterations |
| PT178227831T PT3548006T (pt) | 2016-12-01 | 2017-12-01 | Composição para utilização no tratamento de alterações intestinais |
| ES17822783T ES2968428T3 (es) | 2016-12-01 | 2017-12-01 | Composición para su uso en el tratamiento de alteraciones intestinales |
| US17/102,391 US11690889B2 (en) | 2016-12-01 | 2020-11-23 | Composition for use in the treatment of intestinal alterations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102016000122310A IT201600122310A1 (it) | 2016-12-01 | 2016-12-01 | Composizione per uso nella terapia di alterazioni dell'intestino |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IT201600122310A1 true IT201600122310A1 (it) | 2018-06-01 |
Family
ID=58455455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT102016000122310A IT201600122310A1 (it) | 2016-12-01 | 2016-12-01 | Composizione per uso nella terapia di alterazioni dell'intestino |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10881703B2 (it) |
| EP (1) | EP3548006B1 (it) |
| JP (1) | JP7321935B2 (it) |
| KR (1) | KR102508323B1 (it) |
| CN (1) | CN110430870B (it) |
| AU (1) | AU2017368931B2 (it) |
| BR (1) | BR112019011007A2 (it) |
| CA (1) | CA3045267A1 (it) |
| DK (1) | DK3548006T3 (it) |
| ES (1) | ES2968428T3 (it) |
| FI (1) | FI3548006T3 (it) |
| HR (1) | HRP20231691T1 (it) |
| HU (1) | HUE065202T2 (it) |
| IT (1) | IT201600122310A1 (it) |
| LT (1) | LT3548006T (it) |
| PL (1) | PL3548006T3 (it) |
| PT (1) | PT3548006T (it) |
| RS (1) | RS65009B1 (it) |
| SI (1) | SI3548006T1 (it) |
| WO (1) | WO2018100551A1 (it) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201900008394A1 (it) * | 2019-06-07 | 2020-12-07 | Sofar Spa | Composizione per uso nel trattamento delle malattie infiammatorie croniche intestinali |
| JP2021045103A (ja) * | 2019-09-20 | 2021-03-25 | 国立大学法人秋田大学 | 貪食能測定方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202010008308U1 (de) * | 2010-08-18 | 2010-10-21 | Rittinghausen, Reiner, Dr. | Zusammensetzung zur nutritiven Ergänzung oder Behandlung bei Harnwegsinfekten und/oder bakteriellen Entzündungen der Schleimhäute |
| EP2255661A2 (en) * | 1996-10-16 | 2010-12-01 | Napo Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| WO2012123491A1 (en) * | 2011-03-15 | 2012-09-20 | Velleja Research S.R.L. | Use of type a2 proanthocyanidins in gastroprotected form for the treatment of acute cystitis induced by fimbriated bacterial forms e |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001251610A1 (en) * | 2000-04-13 | 2001-11-07 | Ocean Spray Cranberries, Inc. | Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor |
| US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| US20070243268A1 (en) * | 2005-11-07 | 2007-10-18 | Jaffe Russell M | Compositions for regulating intestinal disorders and methods of use thereof |
| US20070254050A1 (en) * | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
| WO2014032108A1 (en) * | 2012-08-29 | 2014-03-06 | Borody Thomas J | Laxative compositions and methods for treating constipation and related gastrointestinal diseases and conditions |
| CN102823875A (zh) * | 2012-09-10 | 2012-12-19 | 湖北强森魔芋科技有限公司 | 一种高膳食纤维代餐粉及其制备方法 |
| EP2922555A4 (en) * | 2012-11-26 | 2016-06-15 | Borody Thomas J | COMPOSITIONS FOR THE RESTORATION OF AN FECAL MICROBIOTE AND METHODS OF MAKING AND USING THEM |
| ITMI20130793A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
-
2016
- 2016-12-01 IT IT102016000122310A patent/IT201600122310A1/it unknown
-
2017
- 2017-12-01 RS RS20231235A patent/RS65009B1/sr unknown
- 2017-12-01 CN CN201780074055.9A patent/CN110430870B/zh active Active
- 2017-12-01 JP JP2019549668A patent/JP7321935B2/ja active Active
- 2017-12-01 LT LTEPPCT/IB2017/057580T patent/LT3548006T/lt unknown
- 2017-12-01 FI FIEP17822783.1T patent/FI3548006T3/fi active
- 2017-12-01 BR BR112019011007A patent/BR112019011007A2/pt active Search and Examination
- 2017-12-01 US US16/465,511 patent/US10881703B2/en active Active
- 2017-12-01 KR KR1020197018872A patent/KR102508323B1/ko active IP Right Grant
- 2017-12-01 AU AU2017368931A patent/AU2017368931B2/en active Active
- 2017-12-01 SI SI201731468T patent/SI3548006T1/sl unknown
- 2017-12-01 PT PT178227831T patent/PT3548006T/pt unknown
- 2017-12-01 PL PL17822783.1T patent/PL3548006T3/pl unknown
- 2017-12-01 DK DK17822783.1T patent/DK3548006T3/da active
- 2017-12-01 EP EP17822783.1A patent/EP3548006B1/en active Active
- 2017-12-01 CA CA3045267A patent/CA3045267A1/en active Pending
- 2017-12-01 HR HRP20231691TT patent/HRP20231691T1/hr unknown
- 2017-12-01 ES ES17822783T patent/ES2968428T3/es active Active
- 2017-12-01 WO PCT/IB2017/057580 patent/WO2018100551A1/en active Application Filing
- 2017-12-01 HU HUE17822783A patent/HUE065202T2/hu unknown
-
2020
- 2020-11-23 US US17/102,391 patent/US11690889B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2255661A2 (en) * | 1996-10-16 | 2010-12-01 | Napo Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| DE202010008308U1 (de) * | 2010-08-18 | 2010-10-21 | Rittinghausen, Reiner, Dr. | Zusammensetzung zur nutritiven Ergänzung oder Behandlung bei Harnwegsinfekten und/oder bakteriellen Entzündungen der Schleimhäute |
| WO2012123491A1 (en) * | 2011-03-15 | 2012-09-20 | Velleja Research S.R.L. | Use of type a2 proanthocyanidins in gastroprotected form for the treatment of acute cystitis induced by fimbriated bacterial forms e |
Also Published As
| Publication number | Publication date |
|---|---|
| FI3548006T3 (fi) | 2023-12-19 |
| KR102508323B1 (ko) | 2023-03-08 |
| US10881703B2 (en) | 2021-01-05 |
| EP3548006B1 (en) | 2023-11-15 |
| SI3548006T1 (sl) | 2024-02-29 |
| JP7321935B2 (ja) | 2023-08-07 |
| HRP20231691T1 (hr) | 2024-03-15 |
| AU2017368931A1 (en) | 2019-07-04 |
| CA3045267A1 (en) | 2018-06-07 |
| CN110430870B (zh) | 2023-05-23 |
| BR112019011007A2 (pt) | 2019-10-08 |
| RS65009B1 (sr) | 2024-01-31 |
| PL3548006T3 (pl) | 2024-04-29 |
| ES2968428T3 (es) | 2024-05-09 |
| PT3548006T (pt) | 2024-01-16 |
| CN110430870A (zh) | 2019-11-08 |
| RU2019120187A3 (it) | 2021-02-19 |
| DK3548006T3 (da) | 2024-01-02 |
| US20200061141A1 (en) | 2020-02-27 |
| EP3548006A1 (en) | 2019-10-09 |
| AU2017368931B2 (en) | 2022-12-22 |
| KR20190111913A (ko) | 2019-10-02 |
| JP2020500934A (ja) | 2020-01-16 |
| US20210077558A1 (en) | 2021-03-18 |
| US11690889B2 (en) | 2023-07-04 |
| HUE065202T2 (hu) | 2024-05-28 |
| LT3548006T (lt) | 2024-01-10 |
| RU2019120187A (ru) | 2021-01-11 |
| WO2018100551A1 (en) | 2018-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| BR112014016389A8 (pt) | composições e uso das mesmas para o tratamento de distúrbios e doenças hepáticas | |
| PT3302454T (pt) | Composições para utilização no tratamento da doença de parkinson e distúrbios associados | |
| SG11202004408YA (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| FI4101454T3 (fi) | Koostumuksia käytettäviksi kohonneen verenpaineen hoitoon | |
| MA42497A (fr) | Procédés et compositions pour la régulation sélective de l'expression protéique | |
| IT201700025666A1 (it) | Composizione per l’uso nel trattamento dell’ipercolesterolemia e nella prevenzione di patologie cardiovascolari. | |
| DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme | |
| IT201600081379A1 (it) | Composizione farmaceutica per uso nel trattamento delle patologie prostatiche. | |
| IT201700085412A1 (it) | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare | |
| LT3124048T (lt) | Kompozicija skirta vartoti per burną gastroezofaginio refliukso ligos ar skausmo gydymui | |
| IT201600130012A1 (it) | Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale | |
| HK1243709A1 (zh) | 可用於治療阿爾茨海默氏病的四氫呋喃稠合的氨基氫噻嗪衍生物 | |
| IT201600122310A1 (it) | Composizione per uso nella terapia di alterazioni dell'intestino | |
| SG11202001054UA (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| GB2581876B (en) | Compositions for use in the treatment of endometrial disorder | |
| FR3030253B1 (fr) | Composition pour ameliorer l'aspect cellulitique de la peau | |
| IT201700111939A1 (it) | Composizione farmaceutica per l’uso nel trattamento di stati infiammatori | |
| IT201700030541A1 (it) | Composizione e kit per uso nella prevenzione dell’onicomicosi recidivante | |
| EP3475442A4 (en) | 12 (S) -HYDROXYEICOSATRIENOIC ACID COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | |
| IL265911A (en) | Epilimod preparations and methods of using them in the treatment of Alzheimer's disease | |
| ITUB20153759A1 (it) | Composizione antifungina ad uso topico per il trattamento dell'onicomicosi e relativo metodo | |
| ZA201801945B (en) | Compositions and methods for the treatment of parkinson's disease | |
| ITUA20163037A1 (it) | Formulazioni per uso nel trattamento o prevenzione di disturbi urologici | |
| DK3072509T3 (da) | Sammensætninger til behandling af mortellaros sygdom og fremgangsmåder til fremstilling deraf |